Response to Gultekin et al. regarding SECRAB trial toxicity

Research output: Contribution to journal › Letter › peer-review

ASJC Scopus subject areas

@article{6c9b74fd128f41b58bf2a0e6ec9da180,

title = "Response to Gultekin et al. regarding SECRAB trial toxicity",

author = "Fernando, \{Indrajit N.\} and Sian Lax and Ikhlaaq Ahmed",

year = "2020",

month = jun,

doi = "10.1016/j.radonc.2020.01.019",

language = "English",

volume = "147",

pages = "233",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier",

}

TY - JOUR

T1 - Response to Gultekin et al. regarding SECRAB trial toxicity

AU - Fernando, Indrajit N.

AU - Lax, Sian

AU - Ahmed, Ikhlaaq

PY - 2020/6

Y1 - 2020/6

UR - https://www.scopus.com/pages/publications/85086514853

U2 - 10.1016/j.radonc.2020.01.019

DO - 10.1016/j.radonc.2020.01.019

M3 - Letter

SN - 0167-8140

VL - 147

SP - 233

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

ER -